[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 29 of about 29
1. Morse K, Weight M, Molinari R: Extensive postoperative epidural hematoma after full anticoagulation: case report and review of the literature. J Spinal Cord Med; 2007;30(3):282-7
Hazardous Substances Data Bank. HEPARIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extensive postoperative epidural hematoma after full anticoagulation: case report and review of the literature.
  • The objective of this study was to report a case of postoperative epidural hematoma associated with the use of emergent anticoagulation, including the dangers associated with spinal decompression and early postoperative anticoagulation.
  • FINDINGS: After anticoagulation therapy for postoperative myocardial ischemia, the patient developed paresis with ascending abdominal paraesthesias.
  • Magnetic resonance imaging revealed a massive spinal epidural hematoma extending from the middle of the cervical spine to the sacrum.
  • Emergent cervical, thoracic, and revision lumbar laminectomy without fusion was performed to decompress the spinal canal and evacuate the hematoma.
  • Combined cervical, thoracic, and lumbar laminectomy, without instrumentation or fusion, is an acceptable treatment option.
  • [MeSH-major] Anticoagulants / adverse effects. Decompression, Surgical / adverse effects. Hematoma, Epidural, Spinal / etiology. Heparin / adverse effects. Spinal Stenosis / surgery
  • [MeSH-minor] Aged. Humans. Lumbar Vertebrae. Male. Myocardial Ischemia / drug therapy. Myocardial Ischemia / etiology

  • MedlinePlus Health Information. consumer health - Blood Thinners.
  • MedlinePlus Health Information. consumer health - Spinal Stenosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Spinal Disord. 2000 Feb;13(1):46-9 [10710150.001]
  • [Cites] Surg Neurol. 2005 Oct;64(4):295-301; discussion 302 [16181995.001]
  • [Cites] Spine (Phila Pa 1976). 2002 Aug 1;27(15):1670-3 [12163731.001]
  • [Cites] J Neurosurg Anesthesiol. 2003 Jul;15(3):282-5 [12826980.001]
  • [Cites] Spine J. 2003 Mar-Apr;3(2):125-9 [14589226.001]
  • [Cites] Neurosurg Focus. 2004 Jun 15;16(6):e1 [15202871.001]
  • [Cites] Spine (Phila Pa 1976). 2004 Jul 15;29(14):E300-3 [15247592.001]
  • [Cites] J Neurosurg. 1972 Jan;36(1):10-20 [5007267.001]
  • [Cites] J Bone Joint Surg Am. 1986 Mar;68(3):386-91 [2936744.001]
  • [Cites] J Bone Joint Surg Am. 1992 Apr;74(4):536-43 [1583048.001]
  • [Cites] J Neurosurg. 1995 Jul;83(1):1-7 [7782824.001]
  • [Cites] J Bone Joint Surg Am. 1995 Jul;77(7):1042-9 [7608226.001]
  • [Cites] Surg Neurol. 1981 May;15(5):389-401 [9760981.001]
  • [Cites] Neurosurg Focus. 2004 Oct 15;17(4):E5 [15633991.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 2000 Jun;86(4):335-45 [10880933.001]
  • (PMID = 17684896.001).
  • [ISSN] 1079-0268
  • [Journal-full-title] The journal of spinal cord medicine
  • [ISO-abbreviation] J Spinal Cord Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 9005-49-6 / Heparin
  • [Number-of-references] 15
  • [Other-IDs] NLM/ PMC2031966
  •  go-up   go-down


2. Fayad F, Lefevre-Colau MM, Rannou F, Quintero N, Nys A, Macé Y, Poiraudeau S, Drapé JL, Revel M: Relation of inflammatory modic changes to intradiscal steroid injection outcome in chronic low back pain. Eur Spine J; 2007 Jul;16(7):925-31
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A total of 74 patients with LBP and inflammatory Modic changes who showed no response to 3-month conservative treatment received lumbar IDIC.
  • We classified patients with a pure edema endplate changes on MRI as Modic type I (n = 37); those with a mixture of Modic type I and type II changes but predominantly edema changes as Modic I-2 (n = 25) and those with predominantly fatty changes as Modic II-1 (n = 12).
  • No complications such as infection or hematoma were reported.
  • IDIC could be a short-term efficient treatment for patients with chronic LBP and predominantly inflammatory endplate changes when conservative treatments have failed.
  • [MeSH-major] Adrenal Cortex Hormones / administration & dosage. Inflammation / drug therapy. Inflammation / pathology. Intervertebral Disc / drug effects. Low Back Pain / therapy
  • [MeSH-minor] Adult. Aged. Chronic Disease. Female. Humans. Lumbar Vertebrae / pathology. Magnetic Resonance Imaging. Male. Middle Aged. Pilot Projects. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Steroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiol Clin North Am. 2000 Nov;38(6):1207-53, v-vi [11131630.001]
  • [Cites] Spine (Phila Pa 1976). 1992 Jun;17(6 Suppl):S172-5 [1385902.001]
  • [Cites] Radiology. 2001 Feb;218(2):420-7 [11161156.001]
  • [Cites] Radiol Clin North Am. 2001 Jan;39(1):1-29 [11221501.001]
  • [Cites] J Bone Joint Surg Br. 2002 Mar;84(2):196-201 [11924650.001]
  • [Cites] Muscle Nerve. 2003 Mar;27(3):265-84 [12635113.001]
  • [Cites] Spine (Phila Pa 1976). 2004 Apr 15;29(8):833-6; discussion 837 [15082979.001]
  • [Cites] Eur Radiol. 2004 Sep;14(9):1574-81 [15060839.001]
  • [Cites] Spine J. 2004 Sep-Oct;4(5):495-505 [15363419.001]
  • [Cites] Clin Orthop Relat Res. 1969 Nov-Dec;67:100-4 [4243380.001]
  • [Cites] Orthop Clin North Am. 1975 Jan;6(1):259-63 [123053.001]
  • [Cites] Spine (Phila Pa 1976). 1986 Jul-Aug;11(6):650-3 [3787337.001]
  • [Cites] AJR Am J Roentgenol. 1987 Sep;149(3):531-4 [3497539.001]
  • [Cites] Radiology. 1988 Jan;166(1 Pt 1):193-9 [3336678.001]
  • [Cites] Orthop Clin North Am. 1991 Apr;22(2):263-71 [1826550.001]
  • [Cites] Br J Rheumatol. 1994 May;33(5):464-8 [8173852.001]
  • [Cites] J Bone Joint Surg Br. 1994 Sep;76(5):757-64 [8083266.001]
  • [Cites] Spine (Phila Pa 1976). 1995 Feb 1;20(3):341-52 [7732471.001]
  • [Cites] Spine (Phila Pa 1976). 1996 Dec 15;21(24):2833-7; discussion 2838-9 [9112707.001]
  • [Cites] Acta Radiol. 1998 Jan;39(1):18-23 [9498863.001]
  • [Cites] Spine (Phila Pa 1976). 1998 Jul 15;23(14):1612-26 [9682320.001]
  • [Cites] Eur Spine J. 1998;7(5):363-8 [9840468.001]
  • [Cites] Radiology. 1998 Dec;209(3):661-6 [9844656.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 1998 Nov;84(7):583-9 [9881403.001]
  • [Cites] Lancet. 1999 Aug 14;354(9178):581-5 [10470716.001]
  • [Cites] Spine (Phila Pa 1976). 2005 May 15;30(10):1173-80 [15897832.001]
  • [Cites] Spine (Phila Pa 1976). 2005 Aug 1;30(15):1777-85 [16094281.001]
  • [Cites] Cochrane Database Syst Rev. 2006;(2):CD005328 [16625636.001]
  • [Cites] Spine (Phila Pa 1976). 2006 Apr 20;31(9):1026-31 [16641780.001]
  • [Cites] N Engl J Med. 2001 Feb 1;344(5):363-70 [11172169.001]
  • (PMID = 17216228.001).
  • [ISSN] 0940-6719
  • [Journal-full-title] European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
  • [ISO-abbreviation] Eur Spine J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones
  • [Other-IDs] NLM/ PMC2219668
  •  go-up   go-down


3. Shem K: Phlegmasia cerulea dolens: rare complication of vena cava filter placement in man with paraplegia. J Spinal Cord Med; 2008;31(4):398-402
Hazardous Substances Data Bank. WARFARIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Computed tomographic scan suggested a hematoma in the paraspinal and latissimus dorsi muscles.
  • He subsequently developed severe leg pain, followed by hypotension, acute renal failure, and compartment syndrome in bilateral lower extremities requiring fasciotomies.
  • Mechanical and pharmacological thrombectomy was aborted secondary to bleeding complications and hypotension.
  • [MeSH-major] Paraplegia / complications. Spinal Cord Injuries / complications. Thrombophlebitis / etiology. Vena Cava Filters / adverse effects. Venous Thrombosis / therapy
  • [MeSH-minor] Anticoagulants / therapeutic use. Fatal Outcome. Humans. Male. Middle Aged. Pulmonary Embolism / drug therapy. Pulmonary Embolism / etiology. Pulmonary Embolism / radiography. Spinal Fractures / complications. Tomography, X-Ray Computed. Warfarin / therapeutic use

  • Genetic Alliance. consumer health - Paraplegia.
  • MedlinePlus Health Information. consumer health - Deep Vein Thrombosis.
  • MedlinePlus Health Information. consumer health - Spinal Cord Injuries.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1990 May;154(5):1105-6 [2108552.001]
  • [Cites] South Med J. 1989 Jun;82(6):780-2 [2734642.001]
  • [Cites] South Med J. 1988 Mar;81(3):306-12 [3279526.001]
  • [Cites] Am J Surg. 1985 Oct 8;150(4A):64-70 [3901793.001]
  • [Cites] J Trauma. 2004 Jul;57(1):32-6 [15284544.001]
  • [Cites] Can J Cardiol. 2004 Feb;20(2):233-5 [15010749.001]
  • [Cites] J Spinal Cord Med. 2003 Winter;26(4):329-34 [14992332.001]
  • [Cites] J Vasc Surg. 2002 May;35(5):999-1002 [12021718.001]
  • [Cites] J Trauma. 2002 May;52(5):902-6 [11988656.001]
  • [Cites] Am J Surg. 1993 Aug;166(2):206-10 [8352417.001]
  • [Cites] J Spinal Cord Med. 2006;29(3):183-90 [16859222.001]
  • [Cites] Arch Phys Med Rehabil. 2005 Dec;86(12):2240-7 [16344018.001]
  • [Cites] Ann Vasc Surg. 2005 May;19(3):442-7 [15864473.001]
  • [Cites] Am J Surg. 2005 Jun;189(6):656-61 [15910715.001]
  • [Cites] J Vasc Interv Radiol. 2005 Apr;16(4):555-7 [15802458.001]
  • [Cites] Radiology. 1996 Mar;198(3):765-7 [8628868.001]
  • [Cites] J Bone Joint Surg Am. 1995 Mar;77(3):452-4 [7890795.001]
  • (PMID = 18959358.001).
  • [ISSN] 1079-0268
  • [Journal-full-title] The journal of spinal cord medicine
  • [ISO-abbreviation] J Spinal Cord Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 5Q7ZVV76EI / Warfarin
  • [Other-IDs] NLM/ PMC2582430
  •  go-up   go-down


Advertisement
4. Jiménez-Yuste V, Rodriguez-Merchan EC, Alvarez MT, Quintana M, Fernandez I, Hernandez-Navarro F: Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors. Semin Hematol; 2008 Apr;45(2 Suppl 1):S64-7
MedlinePlus Health Information. consumer health - Hemophilia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adequate hemostasis during surgery and postoperative rehabilitation is crucial, as development of a wound hematoma may jeopardize long-term outcomes.
  • It also should be noted that success depends not only on appropriate drug therapy but also on preoperative preparations and adequate perioperative surveillance.
  • [MeSH-major] Blood Coagulation Factor Inhibitors / blood. Hemophilia A / blood. Joint Deformities, Acquired / surgery. Orthopedic Procedures
  • [MeSH-minor] Blood Coagulation Factors / therapeutic use. Elective Surgical Procedures. Factor VIIa / therapeutic use. Humans. Recombinant Proteins / therapeutic use

  • Genetic Alliance. consumer health - Hemophilia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18544428.001).
  • [ISSN] 0037-1963
  • [Journal-full-title] Seminars in hematology
  • [ISO-abbreviation] Semin. Hematol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Blood Coagulation Factor Inhibitors; 0 / Blood Coagulation Factors; 0 / Recombinant Proteins; 0 / recombinant FVIIa; EC 3.4.21.21 / Factor VIIa
  • [Number-of-references] 26
  •  go-up   go-down


5. Chakarian JC, Héron F, Belizna C, Hervé F, Maillochaud JH, Marie I, Lévesque H: [Spontaneous splenic hematoma: trauma injury or drug reaction or both?]. Presse Med; 2005 Dec 17;34(22 Pt 1):1717-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Spontaneous splenic hematoma: trauma injury or drug reaction or both?].
  • [Transliterated title] Hématome spontané de la rate: traumatisme et/ou médicament?
  • CASE: We report the case of a 45-year-old man consulting for abdominal pain that was found to be due to a spontaneous splenic hematoma.
  • This history suggested that the drug might play a role.
  • DISCUSSION: Although the likely cause of this splenic hematoma appears to be a minor injury 9 months before the onset of pain, we cannot rule out the possibility that selective serotonin reuptake inhibitor treatment was a predisposing factor.
  • [MeSH-major] Hematoma / diagnosis. Splenic Diseases / diagnosis
  • [MeSH-minor] Abdominal Pain / etiology. Accidental Falls. Accidents, Occupational. Depression / drug therapy. Humans. Male. Middle Aged. Serotonin Uptake Inhibitors / therapeutic use. Shoulder Joint / injuries

  • MedlinePlus Health Information. consumer health - Spleen Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16374394.001).
  • [ISSN] 0755-4982
  • [Journal-full-title] Presse medicale (Paris, France : 1983)
  • [ISO-abbreviation] Presse Med
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Serotonin Uptake Inhibitors
  •  go-up   go-down


6. Cordero-Ampuero J, de Dios M: What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties? Clin Orthop Relat Res; 2010 Dec;468(12):3268-77
MedlinePlus Health Information. consumer health - Hip Replacement.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Known risk factors for infection after THA include posttraumatic osteoarthritis, previous surgery, chronic liver disease, corticoid therapy, and excessive surgical time.
  • METHODS: We retrospectively compared 47 patients with a hip arthroplasty (23 hemiarthroplasties, 24 total hip arthroplasties) and late infection with 200 randomly-selected patients with primary arthroplasty (100 hemiarthroplasties, 100 total hip arthroplasties) during the same time period of time without any infection during followup.
  • RESULTS: The following factors were more frequent in late infected hemiarthroplasties: female gender; previous surgery; obesity (body mass index greater than 30 kg/m(2)); glucocorticoid and immunosuppressant treatments; prolonged surgical time; inadequate antibiotic prophylaxis; prolonged wound drainage; hematoma; dislocation; and cutaneous, urinary, and/or abdominal infections.
  • The following were more frequent in infected total hip arthroplasties: posttraumatic osteoarthritis; previous surgery; glucocorticoids; chronic liver disease; alcohol and intravenous drug abuse; prolonged surgical time; prolonged wound drainage; dislocation; subsequent surgery; and cutaneous, urinary, respiratory and abdominal infections.
  • [MeSH-minor] Aged. Aged, 80 and over. Chi-Square Distribution. Female. Humans. Incidence. Male. Prevalence. Retrospective Studies. Risk Assessment. Risk Factors. Spain / epidemiology. Time Factors. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 2007 Jan;89(1):33-8 [17200307.001]
  • [Cites] J Hosp Infect. 2006 Jul;63(3):255-62 [16698117.001]
  • [Cites] Clin Infect Dis. 2007 Apr 1;44(7):921-7 [17342642.001]
  • [Cites] Arthritis Rheum. 2007 Mar 15;57(2):327-34 [17330288.001]
  • [Cites] J Am Dent Assoc. 2007 Apr;138(4):458-74; quiz 534-5, 437 [17403736.001]
  • [Cites] Acta Orthop. 2007 Apr;78(2):206-10 [17464608.001]
  • [Cites] Int Orthop. 2007 Aug;31(4):483-5 [16909250.001]
  • [Cites] J Arthroplasty. 2007 Aug;22(5):651-6 [17689771.001]
  • [Cites] J Bone Joint Surg Br. 2007 Dec;89(12):1561-6 [18057353.001]
  • [Cites] Enferm Infecc Microbiol Clin. 2008 Jun-Jul;26(6):380-90 [18588820.001]
  • [Cites] J Bone Joint Surg Br. 2008 Jul;90(7):825-6 [18591586.001]
  • [Cites] J Bone Joint Surg Br. 2008 Jul;90(7):915-9 [18591602.001]
  • [Cites] J Infect. 2008 Jul;57(1):41-6 [18336915.001]
  • [Cites] J Bone Joint Surg Am. 2008 Sep;90(9):2000-12 [18762663.001]
  • [Cites] J Arthroplasty. 2008 Oct;23(7):984-91 [18534466.001]
  • [Cites] Arthritis Rheum. 2008 Dec 15;59(12):1713-20 [19035425.001]
  • [Cites] Enferm Infecc Microbiol Clin. 2008 Dec;26(10):614-20 [19100191.001]
  • [Cites] Psychol Bull. 1992 Jul;112(1):155-9 [19565683.001]
  • [Cites] J Bone Joint Surg Am. 2009 Oct;91(10):2480-90 [19797586.001]
  • [Cites] J Bone Joint Surg Br. 2000 May;82(4):561-5 [10855883.001]
  • [Cites] Instr Course Lect. 2001;50:317-33 [11372331.001]
  • [Cites] J Orthop Res. 2002 May;20(3):506-15 [12038624.001]
  • [Cites] Clin Orthop Relat Res. 2002 Oct;(403):23-8 [12360003.001]
  • [Cites] Acta Orthop Scand. 2002 Dec;73(6):605-10 [12553504.001]
  • [Cites] J Urol. 2003 May;169(5):1796-7 [12686841.001]
  • [Cites] Instr Course Lect. 2003;52:223-45 [12690851.001]
  • [Cites] Clin Orthop Relat Res. 2004 Feb;(419):179-84 [15021151.001]
  • [Cites] Clin Orthop Relat Res. 1976 Nov-Dec;(121):74-82 [825342.001]
  • [Cites] J Bone Joint Surg Br. 1981 Feb;63-B(1):53-7 [7009620.001]
  • [Cites] Clin Orthop Relat Res. 1988 Apr;(229):131-42 [3280197.001]
  • [Cites] Clin Orthop Relat Res. 1990 Dec;(261):63-81 [2245564.001]
  • [Cites] Clin Orthop Relat Res. 1993 Sep;(294):149-54 [8358907.001]
  • [Cites] AJR Am J Roentgenol. 1994 Aug;163(2):377-80 [8037035.001]
  • [Cites] J Bone Joint Surg Am. 1996 Apr;78(4):512-23 [8609130.001]
  • [Cites] Clin Infect Dis. 1998 Nov;27(5):1247-54 [9827278.001]
  • [Cites] J Bone Joint Surg Br. 1999 Jan;81(1):56-9 [10068004.001]
  • [Cites] Instr Course Lect. 1999;48:655-65 [10098095.001]
  • [Cites] J Bone Joint Surg Br. 2005 Jun;87(6):844-50 [15911671.001]
  • [Cites] Clin Orthop Relat Res. 2005 Jun;(435):232-8 [15930944.001]
  • [Cites] J Arthroplasty. 2005 Jun;20(4):460-6 [16124961.001]
  • [Cites] Clin Orthop Relat Res. 2006 Mar;444:176-83 [16523139.001]
  • [Cites] J Arthroplasty. 2006 Apr;21(3):324-9 [16627138.001]
  • [Cites] Acta Orthop. 2006 Dec;77(6):853-65 [17260192.001]
  • (PMID = 20544319.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2974854
  •  go-up   go-down


7. Thakkar SC, Streiff MB, Bruley DF, Mears SC: Case report: perioperative use of protein c concentrate for protein C deficiency in THA. Clin Orthop Relat Res; 2010 Jul;468(7):1986-90
MedlinePlus Health Information. consumer health - Hip Replacement.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We reviewed studies and case reports pertinent to the treatment of patients with protein C deficiency, especially in the perioperative setting.
  • PURPOSES AND CLINICAL RELEVANCE: THA, a particularly high-risk procedure, is associated with a 40% to 70% incidence of venographic deep venous thrombosis and a 2% to 3% incidence of symptomatic deep venous thrombosis.
  • The use of human zymogen protein C in our patient with heterozygous protein C deficiency during the perioperative period of a THA was associated with no evidence of excessive bleeding, hematoma, deep venous thrombosis, or pulmonary embolism.
  • [MeSH-major] Anticoagulants / therapeutic use. Arthroplasty, Replacement, Hip. Intraoperative Complications / prevention & control. Osteoarthritis, Hip / surgery. Protein C / therapeutic use. Protein C Deficiency / drug therapy
  • [MeSH-minor] Aged. Drug Therapy, Combination. Genotype. Heterozygote. Humans. Intraoperative Care. Male. Mutation. Prothrombin / genetics. Pulmonary Embolism / etiology. Pulmonary Embolism / prevention & control. Treatment Outcome. Venous Thrombosis / etiology. Venous Thrombosis / prevention & control

  • Genetic Alliance. consumer health - Protein C Deficiency.
  • MedlinePlus Health Information. consumer health - Blood Thinners.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Intensive Care Med. 2009 Jul;35(7):1187-95 [19263034.001]
  • [Cites] Pathophysiol Haemost Thromb. 2008;36(2):53-7 [19127082.001]
  • [Cites] Crit Care Med. 2000 Jul;28(7):2373-8 [10921567.001]
  • [Cites] Blood. 2000 Dec 1;96(12):3719-24 [11090052.001]
  • [Cites] Br J Haematol. 2002 Mar;116(4):905-8 [11886399.001]
  • [Cites] J Thromb Haemost. 2003 Feb;1(2):387-8 [12871519.001]
  • [Cites] Thromb Haemost. 2003 Sep;90(3):446-55 [12958614.001]
  • [Cites] Chest. 2003 Sep;124(3 Suppl):26S-32S [12970121.001]
  • [Cites] J Bone Joint Surg Am. 1973 Dec;55(8):1629-32 [4217797.001]
  • [Cites] J Clin Invest. 1981 Nov;68(5):1370-3 [6895379.001]
  • [Cites] N Engl J Med. 1983 Aug 11;309(6):340-4 [6688122.001]
  • [Cites] N Engl J Med. 1987 Oct 15;317(16):991-6 [3657866.001]
  • [Cites] J Bone Joint Surg Am. 1989 Sep;71(8):1130-4 [2777838.001]
  • [Cites] J Bone Joint Surg Am. 1991 Apr;73(4):507-12 [2013589.001]
  • [Cites] JAMA. 1992 Jun 3;267(21):2911-5 [1583760.001]
  • [Cites] Lancet. 1993 Jan 16;341(8838):134-8 [8093743.001]
  • [Cites] Transpl Int. 1994;7(2):144-5 [8179804.001]
  • [Cites] Thromb Haemost. 1995 Jan;73(1):87-93 [7740502.001]
  • [Cites] Blood. 1995 May 15;85(10):2756-61 [7742536.001]
  • [Cites] Blood. 1996 Nov 15;88(10):3698-703 [8916933.001]
  • [Cites] Lancet. 1997 Nov 29;350(9091):1590-3 [9393338.001]
  • [Cites] Crit Care. 2005;9 Suppl 4:S38-45 [16168074.001]
  • [Cites] Clin Orthop Relat Res. 2005 Dec;441:40-55 [16330983.001]
  • [Cites] Vox Sang. 2006 May;90(4):294-301 [16635072.001]
  • [Cites] Am J Respir Crit Care Med. 2007 Sep 1;176(5):483-90 [17556722.001]
  • [Cites] Vox Sang. 2007 Oct;93(3):233-40 [17845261.001]
  • [Cites] Drugs Today (Barc). 2008 Jun;44(6):429-41 [18596997.001]
  • [Cites] Circulation. 2008 Oct 14;118(16):1659-67 [18824642.001]
  • [Cites] Crit Care Med. 2009 Jan;37(1):19-25 [19050637.001]
  • [Cites] Intensive Care Med. 2009 Jul;35(7):1196-203 [19367397.001]
  • (PMID = 20012238.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 0 / Protein C; 9001-26-7 / Prothrombin
  • [Other-IDs] NLM/ PMC2882006
  •  go-up   go-down


8. Chakal F, Viso R, Fernández Palazzi F: Percutaneous treatment of haemophilic digital pseudo tumours. Int Orthop; 2005 Jun;29(3):197-8
MedlinePlus Health Information. consumer health - Hemophilia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Percutaneous treatment of haemophilic digital pseudo tumours.
  • If this does not control the growth, surgical treatment is indicated.
  • We have advised a percutaneous treatment with evacuation of the blood and injection of the cavity with fibrin seal.
  • [MeSH-major] Hematoma / drug therapy. Hematoma / surgery. Hemophilia A / complications
  • [MeSH-minor] Adolescent. Child. Drainage / methods. Factor VIII / therapeutic use. Fibrin Tissue Adhesive / administration & dosage. Fingers. Hemostatics / administration & dosage. Hemostatics / therapeutic use. Humans. Injections, Intralesional. Male. Wound Healing / drug effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1972 Jul;115(3):525-39 [5038633.001]
  • [Cites] J Bone Joint Surg Am. 1975 Dec;57(8):1145-6 [1202005.001]
  • [Cites] Am J Dis Child. 1975 Jun;129(6):717-9 [1155404.001]
  • (PMID = 15809872.001).
  • [ISSN] 0341-2695
  • [Journal-full-title] International orthopaedics
  • [ISO-abbreviation] Int Orthop
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Fibrin Tissue Adhesive; 0 / Hemostatics; 9001-27-8 / Factor VIII
  • [Other-IDs] NLM/ PMC3456883
  •  go-up   go-down


9. Bindelglass DF, Rosenblum DS: Neuraxial hematoma and paralysis after enoxaparin administration 3 days after attempted spinal anesthesia for total knee arthroplasty. J Arthroplasty; 2010 Oct;25(7):1169.e9-11
MedlinePlus Health Information. consumer health - Paralysis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neuraxial hematoma and paralysis after enoxaparin administration 3 days after attempted spinal anesthesia for total knee arthroplasty.
  • He was placed on enoxaparin at a therapeutic dose that begun more than 72 hours after his attempted spinal.
  • He developed a spinal hematoma and was paralyzed.
  • The literature has no recommendations for using enoxaparin at therapeutic doses after regional anesthesia.
  • There is no previous report to suggest that a patient 72 hours after surgery is still at risk from a neuraxial hematoma.
  • [MeSH-major] Anesthesia, Spinal. Anticoagulants / adverse effects. Arthroplasty, Replacement, Knee. Enoxaparin / adverse effects. Hematoma, Epidural, Spinal / chemically induced. Paralysis / chemically induced
  • [MeSH-minor] Aged. Dose-Response Relationship, Drug. Humans. Male. Osteoarthritis, Knee / surgery. Pulmonary Embolism / drug therapy. Risk Factors. Time Factors. Venous Thrombosis / prevention & control

  • Genetic Alliance. consumer health - paralysis.
  • MedlinePlus Health Information. consumer health - Blood Thinners.
  • MedlinePlus Health Information. consumer health - Knee Replacement.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 19837550.001).
  • [ISSN] 1532-8406
  • [Journal-full-title] The Journal of arthroplasty
  • [ISO-abbreviation] J Arthroplasty
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 0 / Enoxaparin
  •  go-up   go-down


10. Henry BJ, Kenison M, McVay C, Rolfe R, Graham S, Rasty J, Slauterbeck J, Dabezies EJ: The effect of local hematoma blocks on early fracture healing. Orthopedics; 2002 Nov;25(11):1259-62
Hazardous Substances Data Bank. LIDOCAINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effect of local hematoma blocks on early fracture healing.
  • [MeSH-major] Bupivacaine / pharmacology. Femoral Fractures / drug therapy. Fracture Fixation / methods. Fracture Healing / drug effects. Hematoma / drug therapy. Lidocaine / pharmacology

  • MedlinePlus Health Information. consumer health - Leg Injuries and Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12452343.001).
  • [ISSN] 0147-7447
  • [Journal-full-title] Orthopedics
  • [ISO-abbreviation] Orthopedics
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 98PI200987 / Lidocaine; Y8335394RO / Bupivacaine
  •  go-up   go-down


11. González-Boullosa R, Ocampo-Martínez R, Alarcón-Martín MJ, Suárez-Rodríguez M, Domínguez-Viguera L, González-Fajo G: The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency. Haemophilia; 2005 Mar;11(2):167-70
Genetic Alliance. consumer health - Factor VII Deficiency.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Currently, FV concentrates are not available, and the treatment of spontaneous bleeding or bleeding associated with invasive procedures is transfusion of fresh frozen plasma (FFP).
  • We report a patient with congenital severe FV deficiency with repeated haemarthroses of a shoulder joint, and progressively severe allergic reactions to FFP transfusions.
  • In addition, the patient also developed acute pulmonary oedema.
  • [MeSH-major] Blood Coagulation Factors / therapeutic use. Factor V Deficiency / drug therapy. Factor VII / therapeutic use. Hemarthrosis / prevention & control. Recombinant Proteins / therapeutic use. Shoulder Joint / surgery
  • [MeSH-minor] Factor VIIa. Female. Hematoma / therapy. Hemostasis / physiology. Humans. Middle Aged. Physical Therapy Modalities. Postoperative Complications / therapy. Synovial Membrane / surgery. Treatment Outcome

  • Genetic Alliance. consumer health - Factor V Deficiency.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15810919.001).
  • [ISSN] 1351-8216
  • [Journal-full-title] Haemophilia : the official journal of the World Federation of Hemophilia
  • [ISO-abbreviation] Haemophilia
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Blood Coagulation Factors; 0 / Recombinant Proteins; 0 / recombinant FVIIa; 9001-25-6 / Factor VII; EC 3.4.21.21 / Factor VIIa
  •  go-up   go-down


12. Guo W, Yang RL, Tang XD, Tang S, Li DS, Yang Y: [Resection and reconstruction for primary pelvic tumors around acetabular]. Zhonghua Wai Ke Za Zhi; 2004 Dec 7;42(23):1419-22
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We must pay more attention on the following points in the surgical treatment of periacetabular tumors:.
  • (3) The reconstructed acetabulum is unstable, so the patients must stand with a cane to protect the reconstructed hip joint;.
  • (5) Surgical treatment of pelvic tumors would easily result in poor wound healing especially in the patients receiving chemotherapy or radiotherapy because of extensive soft tissue stripping.
  • The destroyed soft tissue caused by chemotherapy or radiotherapy may increase the great tissue tension after implantation of allograft.
  • And the factors of poor blood supply and hematoma in the wound theoretically increase the chance of infection.

  • MedlinePlus Health Information. consumer health - Hip Replacement.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15733453.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


13. Gomoll AH, Kang RW, Williams JM, Bach BR, Cole BJ: Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder. Arthroscopy; 2006 Aug;22(8):813-9
Hazardous Substances Data Bank. EPINEPHRINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondrolysis after continuous intra-articular bupivacaine infusion: an experimental model investigating chondrotoxicity in the rabbit shoulder.
  • PURPOSE: Postoperative pain pumps are increasingly used to deliver a continuous infusion of local anesthetic into the surgical wound or the joint.
  • An experimental model is presented that investigates potential chondrotoxic effects of a continuous intra-articular infusion of bupivacaine in the rabbit shoulder.
  • METHODS: We divided 30 rabbits into 3 groups that received continuous infusions of either saline solution, bupivacaine, or bupivacaine with epinephrine into the glenohumeral joint over a period of 48 hours.
  • Animals were killed after 1 week, and osteochondral and synovial samples from the glenohumeral joint underwent analyses with confocal microscopy for live/dead cell assay, metabolic sulfate uptake assessment, and conventional histologic analysis.
  • CONCLUSIONS: Continuous intra-articular infusion of bupivacaine with and without epinephrine led to significant histopathologic and metabolic changes in articular cartilage.
  • The results caution against the use of such devices in applications for smaller joints with minimal clearance or dilution as a result of hematoma, where continuous exposure of cartilage to bupivacaine is expected.
  • [MeSH-major] Analgesia, Patient-Controlled / adverse effects. Anesthetics, Local / adverse effects. Bupivacaine / adverse effects. Cartilage Diseases / chemically induced. Shoulder Joint / drug effects
  • [MeSH-minor] Animals. Cartilage, Articular / drug effects. Disease Models, Animal. Drug Combinations. Epinephrine / administration & dosage. Injections, Intra-Articular. Pain, Postoperative / drug therapy. Rabbits. Synovial Membrane / drug effects

  • MedlinePlus Health Information. consumer health - Cartilage Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16904576.001).
  • [ISSN] 1526-3231
  • [Journal-full-title] Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
  • [ISO-abbreviation] Arthroscopy
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anesthetics, Local; 0 / Drug Combinations; Y8335394RO / Bupivacaine; YKH834O4BH / Epinephrine
  •  go-up   go-down


14. Hough RE, Hampton KK, Preston FE, Channer KS, West J, Makris M: Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors. Br J Haematol; 2000 Dec;111(3):974-9
MedlinePlus Health Information. consumer health - Hemophilia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Prothrombin complex concentrates (PCCs) and, more recently, activated prothrombin complex concentrates (APCCs), are widely used for the treatment of active bleeding in haemophiliacs with inhibitors.
  • [MeSH-major] Blood Coagulation Factors / adverse effects. Factor VIIa / therapeutic use. Hemarthrosis / drug therapy. Hemophilia A / complications. Hemophilia A / drug therapy. Myocardial Infarction / etiology
  • [MeSH-minor] Abdomen. Adult. Aged. Blood Coagulation Factor Inhibitors / blood. Factor VIII. Hematoma / drug therapy. Humans. Knee Joint. Male. Recombinant Proteins / adverse effects. Recombinant Proteins / therapeutic use

  • Genetic Alliance. consumer health - Prothrombin.
  • MedlinePlus Health Information. consumer health - Heart Attack.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11122162.001).
  • [ISSN] 0007-1048
  • [Journal-full-title] British journal of haematology
  • [ISO-abbreviation] Br. J. Haematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Blood Coagulation Factor Inhibitors; 0 / Blood Coagulation Factors; 0 / Recombinant Proteins; 37224-63-8 / prothrombin complex concentrates; 9001-27-8 / Factor VIII; EC 3.4.21.21 / Factor VIIa
  • [Number-of-references] 22
  •  go-up   go-down


15. Williams DJ, Thomas GO, Pambakian S, Parker PJ: First military use of activated Factor VII in an APC-III pelvic fracture. Injury; 2005 Mar;36(3):395-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ultrasound scanning (FAST) showed an absent bladder, and a spreading retroperitoneal haematoma combined with intra-abdominal, free blood.
  • Unfortunately he continued to bleed and required transfusion with the unit's entire stock of type-specific blood.
  • [MeSH-major] Factor VIIa / therapeutic use. Fractures, Bone / therapy. Hematoma / drug therapy. Military Personnel. Sacroiliac Joint / injuries
  • [MeSH-minor] Femoral Fractures / surgery. Femoral Fractures / therapy. Fracture Fixation / methods. Humans. Male. Multiple Trauma / surgery. Pelvic Bones / injuries. Pelvic Bones / radiography. Retroperitoneal Space. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Fractures.
  • MedlinePlus Health Information. consumer health - Veterans and Military Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15710156.001).
  • [ISSN] 0020-1383
  • [Journal-full-title] Injury
  • [ISO-abbreviation] Injury
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] EC 3.4.21.21 / Factor VIIa
  •  go-up   go-down


16. Bani A, Spetzger U, Gilsbach JM: Indications for and benefits of lumbar facet joint block: analysis of 230 consecutive patients. Neurosurg Focus; 2002 Aug 15;13(2):E11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Indications for and benefits of lumbar facet joint block: analysis of 230 consecutive patients.
  • OBJECT: The authors evaluated the effectiveness of using a facet joint block with local anesthetic agents and or steroid medication for the treatment of low-back pain in a medium-sized series of patients.
  • METHODS: Over a period of 4 years, the authors performed 715 facet joint injections in 230 patients with variable-length histories of low-back pain.
  • The main parameter for the success or failure of this treatment was the relief of the pain.
  • For the first injection--mainly a diagnostic procedure--the authors used a local anesthetic (1 ml bupivacaine 1%).
  • In two cases the procedure had to be interrupted because of severe pain.
  • There were no cases of infection or hematoma.
  • CONCLUSIONS: Lumbar facet joint block is a minimally invasive procedure to differentiate between facet joint pain and other causes of lower-back pain.
  • The procedure seems to be useful for distinguishing between facet joint pain from postoperative pain due to inappropriate neural decompression after lumbar surgery.
  • [MeSH-major] Lumbar Vertebrae / pathology. Nerve Block / methods. Zygapophyseal Joint / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Low Back Pain / epidemiology. Low Back Pain / pathology. Low Back Pain / therapy. Male. Middle Aged. Pain Measurement

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15916395.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Singelyn FJ, Verheyen CC, Piovella F, Van Aken HK, Rosencher N, EXPERT Study Investigators: The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study. Anesth Analg; 2007 Dec;105(6):1540-7, table of contents

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The benefit-risk ratio of extended fondaparinux therapy has not been assessed in patients undergoing major lower limb joint arthroplasty.
  • We performed a prospective intervention study in patients undergoing major orthopedic surgery primarily designed to assess the efficacy of fondaparinux when drug administration was withheld for 48 h to permit removal of a neuraxial or deep peripheral nerve catheter.
  • The safety and efficacy of extended fondaparinux therapy for the prevention of venous thromboembolism were also evaluated.
  • No neuraxial or perineural hematoma was reported.
  • [MeSH-major] Catheterization / methods. Lower Extremity / surgery. Orthopedic Procedures / methods. Peripheral Nerves. Polysaccharides / administration & dosage. Thrombolytic Therapy / methods
  • [MeSH-minor] Aged. Female. Humans. Internationality. Male. Middle Aged. Postoperative Complications / etiology. Postoperative Complications / prevention & control. Prospective Studies. Time Factors. Venous Thrombosis / etiology. Venous Thrombosis / prevention & control

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Anesth Analg. 2009 Feb;108(2):670-1; author reply 671-2 [19151310.001]
  • (PMID = 18042845.001).
  • [ISSN] 1526-7598
  • [Journal-full-title] Anesthesia and analgesia
  • [ISO-abbreviation] Anesth. Analg.
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Polysaccharides; J177FOW5JL / fondaparinux
  •  go-up   go-down


18. Choi PT, Bhandari M, Scott J, Douketis J: Epidural analgesia for pain relief following hip or knee replacement. Cochrane Database Syst Rev; 2003;(3):CD003071
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • As the use of epidural analgesia may delay the initiation of anticoagulant thromboprophylaxis due to the potential risk of epidural hematoma, a synthesis of the evidence is necessary to determine whether or not alternative analgesic modalities are worse, equivalent, or better than epidural analgesia.
  • REVIEWER'S CONCLUSIONS: Epidural analgesia may be useful for postoperative pain relief following major lower limb joint replacements.
  • [MeSH-major] Arthroplasty, Replacement, Hip / adverse effects. Arthroplasty, Replacement, Knee / adverse effects. Pain, Postoperative / drug therapy
  • [MeSH-minor] Analgesia. Analgesia, Epidural. Anesthesia, Local. Humans. Randomized Controlled Trials as Topic. Time Factors

  • MedlinePlus Health Information. consumer health - Hip Replacement.
  • MedlinePlus Health Information. consumer health - Knee Replacement.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12917945.001).
  • [ISSN] 1469-493X
  • [Journal-full-title] The Cochrane database of systematic reviews
  • [ISO-abbreviation] Cochrane Database Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis; Review
  • [Publication-country] England
  • [Number-of-references] 72
  •  go-up   go-down


19. Luchtman-Jones L, Valentino LA, Manno C, Recombinant Therapy Workshop Participants: Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study. Haemophilia; 2006 Jan;12(1):82-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study.
  • The long-term prophylactic administration of clotting factor concentrate in patients with haemophilia reduces bleeding events, slows joint deterioration, and improves quality of life.
  • While clinical trials are needed to establish the optimal length of prophylaxis following injury, several weeks and possibly months of treatment may be needed.
  • Discontinuing therapy prematurely can result in rebleeding in the injured area.
  • [MeSH-major] Factor VIII / therapeutic use. Hematoma / prevention & control. Hemophilia A / drug therapy
  • [MeSH-minor] Acute Disease. Adult. Craniocerebral Trauma / complications. Hematoma, Subdural, Acute / etiology. Hematoma, Subdural, Acute / prevention & control. Humans. Infant. Leg Injuries / complications. Male. Muscular Diseases / prevention & control. Thigh. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Hemophilia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16409180.001).
  • [ISSN] 1351-8216
  • [Journal-full-title] Haemophilia : the official journal of the World Federation of Hemophilia
  • [ISO-abbreviation] Haemophilia
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / F8 protein, human; 9001-27-8 / Factor VIII
  •  go-up   go-down


20. Lovering AM, Zhang J, Bannister GC, Lankester BJ, Brown JH, Narendra G, MacGowan AP: Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother; 2002 Jul;50(1):73-7
Hazardous Substances Data Bank. LINEZOLID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement.
  • Samples of the haematoma fluid that formed around the operation site and further blood samples for assay were also collected at timed intervals following the operation.
  • Mean concentrations of linezolid in the haematoma fluid drained from around the operation site were 8.2 mg/L at 6-8 h and 5.6 mg/L at 10-12 h after the infusion, and 7.0 mg/L at 2-4 h following a second 600 mg infusion given 12 h post-operatively.
  • We conclude that linezolid exhibits rapid penetration into bone, fat and muscle of patients undergoing hip arthroplasty, to achieve levels in excess of its MIC for susceptible organisms (< or=4 mg/L); therapeutic concentrations were maintained in the haematoma fluid that surrounds the operation site for >16 h.
  • [MeSH-minor] Adipose Tissue / metabolism. Bone and Bones / metabolism. Drug Therapy, Combination. Hematoma / metabolism. Hip Joint / surgery. Humans. Linezolid. Muscles / metabolism. Tissue Distribution

  • MedlinePlus Health Information. consumer health - Hip Replacement.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12096009.001).
  • [ISSN] 0305-7453
  • [Journal-full-title] The Journal of antimicrobial chemotherapy
  • [ISO-abbreviation] J. Antimicrob. Chemother.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Acetamides; 0 / Anti-Infective Agents; 0 / Oxazolidinones; 5CKP8C2LLI / Cefamandole; ISQ9I6J12J / Linezolid
  •  go-up   go-down


21. Kennedy DJ, Dreyfuss P, Aprill CN, Bogduk N: Paraplegia following image-guided transforaminal lumbar spine epidural steroid injection: two case reports. Pain Med; 2009 Nov;10(8):1389-94
Hazardous Substances Data Bank. METHYLPREDNISOLONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Image (fluoroscopic and computed tomography [CT])-guided, lumbar transforaminal injections of corticosteroids have been adopted as a treatment for radicular pain.
  • Both patients developed bilateral lower extremity paralysis, with neurogenic bowel and bladder, immediately after the procedures.
  • There was no evidence of intraspinal mass or hematoma.
  • Distal cord and conus injury can occur following transforaminal injections at lumbar levels, whether injection is on the left or right.
  • [MeSH-major] Fluoroscopy / methods. Low Back Pain / drug therapy. Lumbar Vertebrae / surgery. Paraplegia / chemically induced. Radiculopathy / drug therapy. Steroids / adverse effects
  • [MeSH-minor] Aged. Aged, 80 and over. Arteries / injuries. Arteries / pathology. Arteries / physiopathology. Embolism / chemically induced. Embolism / pathology. Embolism / physiopathology. Female. Humans. Iatrogenic Disease / prevention & control. Infarction / chemically induced. Infarction / pathology. Infarction / physiopathology. Injections, Epidural / adverse effects. Injections, Epidural / methods. Leg / innervation. Leg / physiopathology. Magnetic Resonance Imaging. Male. Methylprednisolone / administration & dosage. Methylprednisolone / adverse effects. Postoperative Complications / etiology. Postoperative Complications / physiopathology. Postoperative Complications / prevention & control. Spinal Cord Injuries / chemically induced. Spinal Cord Injuries / pathology. Spinal Cord Injuries / physiopathology. Surgery, Computer-Assisted / adverse effects. Surgery, Computer-Assisted / methods. Urinary Bladder, Neurogenic / chemically induced. Urinary Bladder, Neurogenic / physiopathology. Zygapophyseal Joint / drug effects. Zygapophyseal Joint / physiopathology

  • Genetic Alliance. consumer health - Paraplegia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19863744.001).
  • [ISSN] 1526-4637
  • [Journal-full-title] Pain medicine (Malden, Mass.)
  • [ISO-abbreviation] Pain Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Steroids; X4W7ZR7023 / Methylprednisolone
  •  go-up   go-down


22. Kennedy RM, Luhmann JD, Luhmann SJ: Emergency department management of pain and anxiety related to orthopedic fracture care: a guide to analgesic techniques and procedural sedation in children. Paediatr Drugs; 2004;6(1):11-31
MedlinePlus Health Information. consumer health - Pain.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Orthopedic fractures and joint dislocations are among the most painful pediatric emergencies.
  • Safe and effective management of fracture-related pain and anxiety in the emergency department reduces patient distress during initial evaluation and often allows definitive management of the fracture.
  • No consensus exists on which pharmacologic regimens for procedural sedation/analgesia are safest and most effective.
  • Effective analgesia can be provided by local or regional anesthesia, such as hematoma, Bier, or nerve blocks.
  • [MeSH-major] Analgesia / methods. Anxiety / drug therapy. Conscious Sedation / methods. Emergency Service, Hospital. Fractures, Bone / complications. Pain / drug therapy
  • [MeSH-minor] Analgesics, Opioid / therapeutic use. Anesthesia Recovery Period. Child. Humans. Monitoring, Physiologic. Parent-Child Relations. Randomized Controlled Trials as Topic

  • Genetic Alliance. consumer health - Anxiety.
  • MedlinePlus Health Information. consumer health - Anxiety.
  • MedlinePlus Health Information. consumer health - Fractures.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br Med J (Clin Res Ed). 1985 Dec 14;291(6510):1683-4 [3935242.001]
  • [Cites] Pain. 1984 Oct;20(2):179-91 [6504552.001]
  • [Cites] Anesthesiology. 2002 Apr;96(4):1004-17 [11964611.001]
  • [Cites] N Engl J Med. 2000 Mar 30;342(13):938-45 [10738053.001]
  • [Cites] Am J Emerg Med. 1996 Oct;14(6):580-1 [8857811.001]
  • [Cites] J Pediatr Orthop. 1992 Sep-Oct;12(5):633-5 [1517425.001]
  • [Cites] J Clin Pharmacol. 1981 Jan;21(1):1-8 [6111570.001]
  • [Cites] Arch Pediatr Adolesc Med. 1996 Jul;150(7):671-5 [8673188.001]
  • [Cites] J Pediatr Orthop. 1996 Mar-Apr;16(2):187-91 [8742282.001]
  • [Cites] Anesthesiology. 1974 May;40(5):459-64 [4822390.001]
  • [Cites] Anesthesiology. 1989 Apr;70(4):622-4 [2929998.001]
  • [Cites] Acta Orthop Scand. 1990 Aug;61(4):348-9 [2205997.001]
  • [Cites] Pediatrics. 2000 Oct;106(4):742-7 [11015517.001]
  • [Cites] Pediatr Clin North Am. 1994 Feb;41(1):111-20 [8295797.001]
  • [Cites] Pediatr Emerg Care. 1996 Dec;12(6):404-6 [8989785.001]
  • [Cites] Pediatr Emerg Care. 1999 Dec;15(6):388-92 [10608322.001]
  • [Cites] Am J Dis Child. 1990 Mar;144(3):270-1 [2305727.001]
  • [Cites] Ann Emerg Med. 2002 Jun;39(6):592-8 [12023700.001]
  • [Cites] Anaesthesia. 1998 May;53 Suppl 2:72-4 [9659077.001]
  • [Cites] Arch Dis Child. 2001 Jun;84(6):492-5 [11369566.001]
  • [Cites] Injury. 1973 May;4(4):345-6 [4710930.001]
  • [Cites] J Orthop Trauma. 1987;1(1):43-7 [2852239.001]
  • [Cites] Anesthesiology. 1990 May;72(5):926-38 [1971164.001]
  • [Cites] Pediatr Clin North Am. 1999 Dec;46(6):1249-84 [10629684.001]
  • [Cites] Anaesth Intensive Care. 1983 Feb;11(1):40-2 [6859507.001]
  • [Cites] Can J Surg. 1993 Jun;36(3):225-8 [8324666.001]
  • [Cites] J Pediatr. 1997 Oct;131(4):582-6 [9386663.001]
  • [Cites] J Orthop Trauma. 1990;4(1):35-8 [2313427.001]
  • [Cites] Ann Emerg Med. 2000 Mar;35(3):297-9 [10692201.001]
  • [Cites] Can Anaesth Soc J. 1982 May;29(3):270-1 [7074406.001]
  • [Cites] Crit Care Med. 1988 Mar;16(3):238-40 [3257727.001]
  • [Cites] Ann Emerg Med. 2000 Nov;36(5):480-2 [11054203.001]
  • [Cites] Ann Emerg Med. 1998 Jun;31(6):688-97 [9624307.001]
  • [Cites] Ann Chir Gynaecol. 1990;79(3):168-71 [2264720.001]
  • [Cites] Injury. 1985 Jul;16(7):469-70 [4030071.001]
  • [Cites] Pediatrics. 2003 Jul;112(1 Pt 1):116-23 [12837876.001]
  • [Cites] Am J Emerg Med. 1998 Jul;16(4):353-6 [9672449.001]
  • [Cites] Acad Emerg Med. 1998 Feb;5(2):112-7 [9492130.001]
  • [Cites] Pediatrics. 1998 Oct;102(4 Pt 1):956-63 [9755272.001]
  • [Cites] J Pediatr Orthop. 1994 Jul-Aug;14(4):534-7 [8077441.001]
  • [Cites] J Pediatr Orthop. 1988 Sep-Oct;8(5):576-9 [3170738.001]
  • [Cites] Pediatr Dent. 1993 Mar-Apr;15(2):88-92 [8327365.001]
  • [Cites] Pediatr Emerg Care. 1998 Apr;14(2):99-103 [9583388.001]
  • [Cites] Pediatr Emerg Care. 1996 Aug;12(4):268-71 [8858650.001]
  • [Cites] Pediatr Emerg Care. 1996 Feb;12 (1):31-5 [8677176.001]
  • [Cites] Ann Emerg Med. 2000 Dec;36(6):579-88 [11097698.001]
  • [Cites] J Pediatr Orthop. 1991 Nov-Dec;11(6):717-20 [1960193.001]
  • [Cites] Lancet. 2001 Nov 3;358(9292):1514-5 [11705568.001]
  • [Cites] Ann Emerg Med. 1993 Feb;22(2):201-5 [8427432.001]
  • [Cites] Anesthesiology. 1994 Oct;81(4):1005-43 [7943815.001]
  • [Cites] J Bone Joint Surg Am. 1995 Mar;77(3):335-9 [7890780.001]
  • [Cites] Pediatrics. 1995 Apr;95(4):598-602 [7700765.001]
  • [Cites] Anesthesiology. 1979 Oct;51(4):285-7 [484889.001]
  • [Cites] J Pediatr Orthop. 1995 Jan-Feb;15(1):73-7 [7883933.001]
  • [Cites] Drugs. 1995 Sep;50(3):513-59 [8521772.001]
  • [Cites] Crit Care Med. 2002 Jun;30(6):1231-6 [12072673.001]
  • [Cites] Pediatr Clin North Am. 2000 Jun;47(3):559-87 [10835991.001]
  • [Cites] Pediatrics. 1991 Apr;87(4):544-8 [2011433.001]
  • [Cites] J Emerg Med. 1991 Jul-Aug;9(4):247-51 [1861059.001]
  • [Cites] Ann Emerg Med. 1999 Oct;34(4 Pt 1):483-91 [10499949.001]
  • [Cites] Anesth Prog. 1997 Winter;44(1):1-4 [9481973.001]
  • [Cites] Nat Med. 1998 Apr;4(4):460-3 [9546794.001]
  • [Cites] Pediatr Clin North Am. 2000 Jun;47(3):651-79 [10835996.001]
  • [Cites] Pediatr Clin North Am. 1999 Dec;46(6):1215-47, vii-viii [10629683.001]
  • [Cites] J Orthop Trauma. 1989;3(3):187-91 [2809817.001]
  • [Cites] Online J Curr Clin Trials. 1992 Oct 1;Doc No 23:[3614 words; 43 paragraphs] [1343612.001]
  • [Cites] Spine (Phila Pa 1976). 1998 Apr 1;23(7):834-8 [9563116.001]
  • [Cites] Arch Pediatr Adolesc Med. 1996 Jul;150(7):665-7 [8673187.001]
  • [Cites] Arch Emerg Med. 1987 Sep;4(3):163-8 [3689541.001]
  • [Cites] Orthopedics. 1997 May;20(5):423-6 [9172249.001]
  • [Cites] Paediatr Drugs. 2001;3(5):337-54 [11393327.001]
  • [Cites] Anesth Analg. 1987 Jun;66(6):572-4 [3034106.001]
  • [Cites] Acad Emerg Med. 2002 Apr;9(4):275-80 [11927449.001]
  • [Cites] Ann Emerg Med. 2003 Dec;42(6):773-82 [14634602.001]
  • [Cites] Ann Emerg Med. 1990 Sep;19(9):1024-32 [2393169.001]
  • [Cites] Acad Emerg Med. 2001 Jan;8(1):13-8 [11136141.001]
  • [Cites] Ann Emerg Med. 1990 Sep;19(9):1033-46 [2203290.001]
  • [Cites] Anesthesiology. 1982 Feb;56(2):119-36 [6892475.001]
  • [Cites] Ann Emerg Med. 1998 Jan;31(1):36-40 [9437339.001]
  • [Cites] J Bone Joint Surg Br. 1988 Jan;70(1):84 [3339065.001]
  • [Cites] J Clin Anesth. 1995 Jun;7(4):273-80 [7546752.001]
  • [Cites] J Bone Joint Surg Am. 2000 Jul;82-A(7):912-8 [10901305.001]
  • [Cites] Am J Emerg Med. 2001 Sep;19(5):399-402 [11555797.001]
  • [Cites] Ann Emerg Med. 1991 Oct;20(10):1100-3 [1928881.001]
  • [Cites] Pediatrics. 1990 Sep;86(3):463-7 [2388795.001]
  • [Cites] Clin Pharmacol Ther. 1990 Nov;48(5):555-67 [2225714.001]
  • [Cites] Anaesthesia. 1977 Jun;32(6):576-7 [879471.001]
  • [Cites] Ann Emerg Med. 1992 Jan;21(1):16-9 [1539881.001]
  • [Cites] Ann Emerg Med. 1988 Feb;17(2):117-20 [2827545.001]
  • [Cites] Ann Emerg Med. 2000 Mar;35(3):229-38 [10692189.001]
  • [Cites] Pediatrics. 2000 Apr;105(4):E47 [10742368.001]
  • [Cites] Acad Emerg Med. 1999 Oct;6(10):989-97 [10530656.001]
  • [Cites] Anesth Analg. 1998 Nov;87(5):1186-93 [9806706.001]
  • [Cites] Ann Emerg Med. 2001 Jan;37(1):20-7 [11145766.001]
  • [Cites] Pediatrics. 1992 Jun;89(6 Pt 1):1110-5 [1594358.001]
  • [Cites] Clin Pediatr (Phila). 2001 Dec;40(12):663-71 [11771920.001]
  • [Cites] Clin Pharmacol Ther. 1980 Jul;28(1):106-14 [7389247.001]
  • [Cites] J Pediatr Orthop. 1994 Jul-Aug;14(4):538-42 [8077442.001]
  • [Cites] J Orthop Trauma. 1995 Apr;9(2):113-6 [7776029.001]
  • [Cites] J Burn Care Rehabil. 2002 Jan-Feb;23(1):27-31 [11803309.001]
  • [Cites] Acad Emerg Med. 1999 Jan;6(1):21-6 [9928972.001]
  • [Cites] Acad Emerg Med. 2001 Jan;8(1):68-9 [11136153.001]
  • [Cites] J Trauma. 1995 Oct;39(4):726-8 [7473964.001]
  • [Cites] Pediatr Emerg Care. 1999 Jun;15(3):173-5 [10389951.001]
  • [Cites] Pediatr Emerg Care. 1997 Jun;13(3):189-93 [9220504.001]
  • [Cites] Aust N Z J Surg. 1979 Oct;49(5):592-4 [292412.001]
  • [Cites] Acad Emerg Med. 1999 Oct;6(10):975-8 [10530652.001]
  • [Cites] Anesthesiology. 1990 Nov;73(5):826-30 [2122773.001]
  • [Cites] Orthop Rev. 1991 Nov;20(11):977-9 [1749663.001]
  • [Cites] J Orthop Trauma. 1995;9(5):407-10 [8537844.001]
  • [Cites] Anesthesiology. 1999 Mar;90(3):896-905 [10078693.001]
  • [Cites] Acad Emerg Med. 2001 Jan;8(1):74-7 [11136155.001]
  • [Cites] Acad Emerg Med. 2002 Jan;9(1):35-42 [11772667.001]
  • [Cites] J Hand Surg Br. 1989 May;14(2):194-5 [2746120.001]
  • [Cites] J Oral Maxillofac Surg. 1991 May;49(5):519-23 [2019899.001]
  • [Cites] Acad Emerg Med. 1997 Nov;4(11):1032-5 [9383487.001]
  • [Cites] Anesthesiology. 1999 Jan;90(1):66-71 [9915314.001]
  • (PMID = 14969567.001).
  • [ISSN] 1174-5878
  • [Journal-full-title] Paediatric drugs
  • [ISO-abbreviation] Paediatr Drugs
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Analgesics, Opioid
  • [Number-of-references] 131
  •  go-up   go-down


23. Barnes B, Alexander JT, Branch CL Jr: Postoperative Level 1 anticoagulation therapy and spinal surgery: practical guidelines for management. Neurosurg Focus; 2004 Oct 15;17(4):E5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postoperative Level 1 anticoagulation therapy and spinal surgery: practical guidelines for management.
  • OBJECT: The authors conducted a review of the literature to establish reasonable practical guidelines for the management of complications in patients who have undergone recent spinal surgery and who require Level 1 anticoagulation therapy.
  • METHODS: A MEDLINE (PubMed) literature search was performed using the key words "postoperative anticoagulation," "spinal surgery," and "postoperative epidural hematoma," for articles published between 1990 and 2004.
  • The search yielded 148 articles, which were then further screened for relevance and classified according to level-of-evidence guidelines established by the American Association of Neurological Surgeons/Congress of Neurological Surgeons joint committee for spinal cord injury.
  • In patients who undergo spinal surgery and who require heparinization therapy for myocardial ischemia or infarction, the use of frequent neurological examinations in conjunction with anticoagulation therapy seems to be the only reasonable option.
  • [MeSH-major] Anticoagulants / therapeutic use. Postoperative Care / methods. Postoperative Care / standards. Practice Guidelines as Topic / standards. Spinal Cord Injuries / drug therapy. Spinal Cord Injuries / surgery

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Blood Thinners.
  • MedlinePlus Health Information. consumer health - Spinal Cord Injuries.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15633991.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants
  • [Number-of-references] 19
  •  go-up   go-down


24. Hadjipavlou AG, Katonis PG, Tzermiadianos MN, Tsoukas GM, Sapkas G: Principles of management of osteometabolic disorders affecting the aging spine. Eur Spine J; 2003 Oct;12 Suppl 2:S113-31
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this context, one must be certain before attributing low back pain to PD exclusively, and antipagetic medical treatment alone may be ineffective.
  • Neural element dysfunction may be attributed to compressive myelopathy by pagetic bone overgrowth, pagetic intraspinal soft tissue overgrowth, ossification of epidural fat, platybasia, spontaneous bleeding, sarcomatous degeneration and vertebral fracture or subluxation.
  • Because the effectiveness of pharmacologic treatment for pagetic spinal stenosis has been clearly demonstrated, surgical decompression should only be instituted after failure of antipagetic medical treatment.
  • Surgery is indicated as a primary treatment when neural compression is secondary to pathologic fractures, dislocations, spontaneous epidural hematoma, syringomyelia, platybasia, or sarcomatous transformation.
  • Five classes of drugs are available for the treatment of PD.
  • Bisphosphonates are the most popular antipagetic drug and several forms have been investigated.
  • [MeSH-minor] Aged. Humans. Orthopedic Procedures / methods. Spinal Stenosis / etiology. Spinal Stenosis / pathology. Spinal Stenosis / therapy

  • MedlinePlus Health Information. consumer health - Osteoporosis.
  • MedlinePlus Health Information. consumer health - Paget's Disease of Bone.
  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • MedlinePlus Health Information. consumer health - Spine Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 1977;(127):106-10 [144039.001]
  • [Cites] Clin Orthop Relat Res. 1977;(127):37-42 [912992.001]
  • [Cites] J Bone Joint Surg Am. 1977 Dec;59(8):1045-51 [145441.001]
  • [Cites] Spine (Phila Pa 1976). 1979 Jan-Feb;4(1):37-40 [432714.001]
  • [Cites] Neurology. 1979 Apr;29(4):448-57 [220561.001]
  • [Cites] Clin Orthop Relat Res. 1979 Jun;(141):260-5 [89924.001]
  • [Cites] Br J Radiol. 1980 Apr;53(628):286-8 [7378695.001]
  • [Cites] Lancet. 1980 Jul 5;2(8184):13-5 [6104224.001]
  • [Cites] Arthritis Rheum. 1980 Oct;23(10):1121-7 [6448603.001]
  • [Cites] Arthritis Rheum. 1980 Oct;23(10):1185-92 [6448604.001]
  • [Cites] Radiology. 1981 Nov;141(2):363-4 [7291557.001]
  • [Cites] J Bone Joint Surg Br. 1981;63B(4):495-503 [6457839.001]
  • [Cites] J Bone Joint Surg Br. 1983 May;65(3):299-307 [6573330.001]
  • [Cites] J Nucl Med. 1983 Oct;24(10):880-5 [6225840.001]
  • [Cites] JAMA. 1984 Aug 10;252(6):799-802 [6748181.001]
  • [Cites] N Engl J Med. 1986 Jun 26;314(26):1676-86 [3520321.001]
  • [Cites] Radiology. 1986 Jul;160(1):155-9 [2940618.001]
  • [Cites] Clin Orthop Relat Res. 1986 Jul;(208):15-9 [3720116.001]
  • [Cites] J Bone Joint Surg Br. 1986 May;68(3):431-8 [2942548.001]
  • [Cites] Union Med Can. 1986 Oct;115(10):746-50 [3798601.001]
  • [Cites] Clin Orthop Relat Res. 1987 Apr;(217):152-61 [2951047.001]
  • [Cites] Clin Orthop Relat Res. 1987 Apr;(217):37-44 [3103964.001]
  • [Cites] Clin Orthop Relat Res. 1987 Apr;(217):72-8 [3549097.001]
  • [Cites] Orthop Clin North Am. 1990 Jan;21(1):143-50 [2404233.001]
  • [Cites] Am Rev Respir Dis. 1990 Jan;141(1):68-71 [2297189.001]
  • [Cites] Int J Epidemiol. 1990 Jun;19(2):455-8 [2376461.001]
  • [Cites] Spine (Phila Pa 1976). 1990 Jun;15(6):485-9 [2402688.001]
  • [Cites] J Rheumatol. 1990 Jul;17(7):975-8 [2213767.001]
  • [Cites] Spine (Phila Pa 1976). 1990 Sep;15(9):902-7 [2259978.001]
  • [Cites] Spine (Phila Pa 1976). 1991 Jan;16(1):46-51 [1825894.001]
  • [Cites] Ann Intern Med. 1991 Jun 1;114(11):919-23 [2024857.001]
  • [Cites] Scott Med J. 1991 Apr;36(2):49 [1906636.001]
  • [Cites] J Bone Joint Surg Am. 1991 Oct;73(9):1376-81 [1833408.001]
  • [Cites] Spine (Phila Pa 1976). 1991 Nov;16(11):1335-41 [1750009.001]
  • [Cites] Bone. 1995 Nov;17(5 Suppl):485S-488S [8573423.001]
  • [Cites] Bone. 1995 Nov;17(5 Suppl):505S-511S [8573428.001]
  • [Cites] Spine (Phila Pa 1976). 1996 Feb 1;21(3):288-94 [8742203.001]
  • [Cites] Orthop Rev. 1994 Sep;23(9):715-24 [7800400.001]
  • [Cites] Spine (Phila Pa 1976). 1994 Nov 1;19(21):2415-20 [7846594.001]
  • [Cites] Eur Spine J. 1994;3(5):286-8 [7866853.001]
  • [Cites] Spine (Phila Pa 1976). 1995 Feb 15;20(4):454-9 [7747229.001]
  • [Cites] Paraplegia. 1995 May;33(5):281-9 [7630656.001]
  • [Cites] Rev Med Interne. 1995;16(12):891-6 [8570951.001]
  • [Cites] AJR Am J Roentgenol. 1999 Dec;173(6):1685-90 [10584820.001]
  • [Cites] J Bone Miner Res. 2000 Mar;15(3):461-5 [10750560.001]
  • [Cites] Bone. 2000 Jun;26(6):577-80 [10831928.001]
  • [Cites] Spine (Phila Pa 1976). 2000 Nov 1;25(21):2832-5 [11064531.001]
  • [Cites] Spine (Phila Pa 1976). 2001 Jul 15;26(14):1511-5 [11462078.001]
  • [Cites] Spine (Phila Pa 1976). 2001 Jul 15;26(14):1631-8 [11464159.001]
  • [Cites] Eur Spine J. 2001 Oct;10(5):370-84 [11718191.001]
  • [Cites] Australas Radiol. 1975 Mar;19(1):15-9 [1147857.001]
  • [Cites] Clin Orthop Relat Res. 1987 Apr;(217):9-15 [3549098.001]
  • [Cites] J Neurosurg. 1987 Apr;66(4):611-3 [3559728.001]
  • [Cites] J Bone Joint Surg Am. 1987 Jul;69(6):843-50 [3597497.001]
  • [Cites] Radiology. 1987 Nov;165(2):533-5 [3659378.001]
  • [Cites] Z Orthop Ihre Grenzgeb. 1987 May-Jun;125(3):320-3 [3673182.001]
  • [Cites] Clin Radiol. 1988 Jan;39(1):51-2 [3338241.001]
  • [Cites] Clin Exp Rheumatol. 1987 Oct-Dec;5(4):377-8 [3440335.001]
  • [Cites] Spine (Phila Pa 1976). 1988 Jan;13(1):128-30 [3381126.001]
  • [Cites] Surg Neurol. 1988 Aug;30(2):131-4 [3400040.001]
  • [Cites] Spine (Phila Pa 1976). 1988 Feb;13(2):222-4 [3043720.001]
  • [Cites] Spine (Phila Pa 1976). 1989 Jan;14(1):114-7 [2913656.001]
  • [Cites] Am J Med. 1996 Oct;101(4):341-8 [8873503.001]
  • [Cites] Int Orthop. 1996;20(1):35-42 [8881888.001]
  • [Cites] J Spinal Disord. 1997 Feb;10(1):12-9 [9041491.001]
  • [Cites] Spine (Phila Pa 1976). 1997 May 1;22(9):958-62; discussion 963 [9152444.001]
  • [Cites] Spine (Phila Pa 1976). 1997 Aug 1;22(15):1696-705 [9259778.001]
  • [Cites] Spine (Phila Pa 1976). 1997 Aug 15;22(16):1928-32 [9280031.001]
  • [Cites] Rev Rhum Engl Ed. 1997 Jul-Sep;64(7-9):495-9 [9338932.001]
  • [Cites] Spine (Phila Pa 1976). 1997 Dec 1;22(23):2716-23 [9431604.001]
  • [Cites] Spine (Phila Pa 1976). 1997 Dec 15;22(24 Suppl):43S-48S [9431644.001]
  • [Cites] Clin Ther. 1997 Nov-Dec;19(6):1309-29; discussion 1523-4 [9444442.001]
  • [Cites] Clin Biochem. 1997 Dec;30(8):573-93 [9455610.001]
  • [Cites] Medicina (B Aires). 1997;57 Suppl 1:65-75 [9567358.001]
  • [Cites] Rev Rhum Engl Ed. 1998 Mar;65(3):207-11 [9574479.001]
  • [Cites] J Bone Miner Res. 1998 Jun;13(6):911-7 [9626621.001]
  • [Cites] Osteoporos Int. 1998;8(3):261-7 [9797911.001]
  • [Cites] Spine (Phila Pa 1976). 1998 Oct 15;23(20):2201-6 [9802162.001]
  • [Cites] Radiology. 1998 Dec;209(3):641-51 [9844654.001]
  • [Cites] Ann Diagn Pathol. 1999 Apr;3(2):99-103 [10196390.001]
  • [Cites] Bone. 1999 May;24(5 Suppl):19S-21S [10321921.001]
  • [Cites] Bone. 1999 May;24(5 Suppl):47S-48S [10321927.001]
  • [Cites] Arch Intern Med. 1999 Jun 14;159(11):1215-20 [10371229.001]
  • [Cites] AMA Arch Intern Med. 1952 Nov;90(5):610-33 [12984862.001]
  • [Cites] Lancet. 1956 Jul 14;271(6933):51-7 [13347083.001]
  • [Cites] Lancet. 1957 Jun 8;272(6980):1170-1 [13439994.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1946 Jul;9(3):84-6 [20293589.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1972 Dec;35(6):825-8 [4647855.001]
  • [Cites] J Bone Joint Surg Br. 2002 Mar;84(2):160-9 [11922354.001]
  • [Cites] Am J Orthop (Belle Mead NJ). 2002 Mar;31(3):123-7; discussion 128 [11922454.001]
  • [Cites] South Med J. 2002 Jun;95(6):583-7 [12081214.001]
  • [Cites] Spine (Phila Pa 1976). 2002 Oct 1;27(19):2173-8; discussion 2178-9 [12394934.001]
  • [Cites] J Spinal Disord Tech. 2003 Feb;16(1):10-9 [12571479.001]
  • [Cites] Osteoporos Int. 2003 Jan;14(1):69-76 [12577187.001]
  • [Cites] Spine (Phila Pa 1976). 2002 Sep 15;27(18):E413-5 [12634579.001]
  • [Cites] J Bone Joint Surg Br. 1966 May;48(2):365-70 [5937602.001]
  • [Cites] J Bone Joint Surg Am. 1966 Sep;48(6):1079-84 [5917697.001]
  • [Cites] Clin Radiol. 1968 Oct;19(4):421-5 [5716984.001]
  • [Cites] Br J Surg. 1970 Mar;57(3):239-40 [5440229.001]
  • [Cites] Rev Rhum Mal Osteoartic. 1970 May;37(5):385-8 [5454831.001]
  • [Cites] Am J Med. 1970 Oct;49(4):494-503 [4320120.001]
  • [Cites] J Neurosurg. 1972 Dec;37(6):661-5 [4511088.001]
  • [Cites] Am J Med. 1974 May;56(5):592-603 [4825603.001]
  • [Cites] Aust N Z J Surg. 1992 Jan;62(1):33-8 [1531008.001]
  • [Cites] J Bone Miner Res. 1992 Feb;7(2):221-7 [1570766.001]
  • [Cites] Bone. 1992;13 Suppl 2:S27-31 [1627411.001]
  • [Cites] Spine (Phila Pa 1976). 1992 Aug;17(8 Suppl):S295-303 [1523516.001]
  • [Cites] Am J Med. 1993 Jun;94(6):595-601 [8506884.001]
  • [Cites] Osteoporos Int. 1993 Jul;3(4):215-21 [8338978.001]
  • [Cites] Spine (Phila Pa 1976). 1993 Oct 15;18(14):2131-4 [8272970.001]
  • [Cites] Spine (Phila Pa 1976). 1993 Nov;18(15):2240-5 [8278839.001]
  • [Cites] Spine (Phila Pa 1976). 1994 Aug 1;19(15):1680-5 [7973960.001]
  • [Cites] Br J Surg. 1975 Jul;62(7):571-2 [809080.001]
  • [Cites] Nouv Presse Med. 1976 Nov;5(39):2619-21 [995592.001]
  • [Cites] Union Med Can. 1977 Aug;106(8):1100-9 [906151.001]
  • (PMID = 14505119.001).
  • [ISSN] 0940-6719
  • [Journal-full-title] European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
  • [ISO-abbreviation] Eur Spine J
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 137
  • [Other-IDs] NLM/ PMC3591829
  •  go-up   go-down


25. Wissel J, Müller J, Dressnandt J, Heinen F, Naumann M, Topka H, Poewe W: Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage; 2000 Jul;20(1):44-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pharmacological treatment with oral antispasticity drugs is frequently associated with systemic side effects which limit their clinical use.
  • Intramuscular BtxA injections were placed in muscles exhibiting increased muscle tone in combination with pain during passive joint movement.
  • Patients received a mean total dose of 165.7 +/- 108.2 [30-400] units BOTOX((R)) per treatment session in a mean 3.4 +/- 1.5 muscles.
  • Mild reversible side effects (local pain, hematoma, edema, mild weakness) were observed in four patients.
  • In conclusion, we found that intramuscular BtxA injections are a potent, well-tolerated treatment modality to significantly reduce spasticity-related local pain.
  • This problem may be a main indication, especially in patients with poor response or intolerable side effects to oral medication.
  • [MeSH-major] Botulinum Toxins, Type A / therapeutic use. Muscle Spasticity / complications. Neuromuscular Agents / therapeutic use. Pain / drug therapy

  • Genetic Alliance. consumer health - Spasticity.
  • MedlinePlus Health Information. consumer health - Botox.
  • MedlinePlus Health Information. consumer health - Pain.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10946168.001).
  • [ISSN] 0885-3924
  • [Journal-full-title] Journal of pain and symptom management
  • [ISO-abbreviation] J Pain Symptom Manage
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Multicenter Study
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Neuromuscular Agents; EC 3.4.24.69 / Botulinum Toxins, Type A
  •  go-up   go-down


26. Lee JY, Nassr A, Ponnappan RK: Epidural hematoma causing paraplegia after a fluoroscopically guided cervical nerve-root injection. A case report. J Bone Joint Surg Am; 2007 Sep;89(9):2037-9
Genetic Alliance. consumer health - Paraplegia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidural hematoma causing paraplegia after a fluoroscopically guided cervical nerve-root injection. A case report.
  • [MeSH-major] Analgesia, Epidural / adverse effects. Fluoroscopy. Hematoma, Epidural, Spinal / etiology. Paraplegia / etiology. Radiography, Interventional
  • [MeSH-minor] Adult. Female. Follow-Up Studies. Humans. Injections, Epidural / adverse effects. Magnetic Resonance Imaging. Radiculopathy / drug therapy. Spinal Nerve Roots / drug effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17768203.001).
  • [ISSN] 0021-9355
  • [Journal-full-title] The Journal of bone and joint surgery. American volume
  • [ISO-abbreviation] J Bone Joint Surg Am
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Riepe G, Schneider M: [V.A.C. instill -- first experiences on an inflammatory process of the proximal femur 3 years after hip-joint operation]. Zentralbl Chir; 2006 Apr;131 Suppl 1:S157-9
MedlinePlus Health Information. consumer health - Abscess.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [V.A.C. instill -- first experiences on an inflammatory process of the proximal femur 3 years after hip-joint operation].
  • [MeSH-major] Abscess / surgery. Drug Therapy, Computer-Assisted / instrumentation. Hip Prosthesis. Instillation, Drug. Occlusive Dressings. Prosthesis Failure. Prosthesis-Related Infections / surgery. Surgical Wound Infection / surgery. Thigh / surgery
  • [MeSH-minor] Combined Modality Therapy. Debridement. Hematoma / complications. Humans. Male. Middle Aged. Postoperative Care. Reoperation. Seroma / complications. Vacuum

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16575670.001).
  • [ISSN] 0044-409X
  • [Journal-full-title] Zentralblatt für Chirurgie
  • [ISO-abbreviation] Zentralbl Chir
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


28. Zermatten P, Angelillo-Scherrer A, Theumann N, Dutoit M, Chevalley F: Painful periarticular calcifications after muscle injury at the hip in a patient with moderate haemophilia A. Haemophilia; 2008 May;14(3):651-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Coagulants / therapeutic use. Factor VIII / therapeutic use. Hemophilia A / complications. Ossification, Heterotopic / complications. Wounds, Nonpenetrating / complications
  • [MeSH-minor] Adult. Hematoma / etiology. Hip Joint. Humans. Magnetic Resonance Imaging. Male. Muscle, Skeletal / injuries. Pain / drug therapy. Pain / etiology. Pelvis. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Hemophilia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18393982.001).
  • [ISSN] 1365-2516
  • [Journal-full-title] Haemophilia : the official journal of the World Federation of Hemophilia
  • [ISO-abbreviation] Haemophilia
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Coagulants; 0 / F8 protein, human; 9001-27-8 / Factor VIII
  •  go-up   go-down


29. Saarela MS, Tiitola M, Lappalainen K, Vikatmaa P, Pinomäki A, Alberty A, Lassila R: Pseudoaneurysm in association with a knee endoprothesis operation in an inhibitor-positive haemophilia A patient - treatment with local thrombin. Haemophilia; 2010 Jul 1;16(4):686-8
MedlinePlus Health Information. consumer health - Hemophilia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pseudoaneurysm in association with a knee endoprothesis operation in an inhibitor-positive haemophilia A patient - treatment with local thrombin.
  • [MeSH-major] Aneurysm, False / drug therapy. Hemarthrosis / therapy. Hemophilia A. Hemostatics / therapeutic use. Knee Prosthesis / adverse effects. Synovial Membrane. Thrombin / therapeutic use
  • [MeSH-minor] Adult. Blood Coagulation Factor Inhibitors. Factor VIII / antagonists & inhibitors. Factor VIIa / administration & dosage. Factor VIIa / therapeutic use. Hematoma / ultrasonography. Humans. Knee Joint / ultrasonography. Male. Postoperative Complications. Recombinant Proteins / administration & dosage. Recombinant Proteins / therapeutic use. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20201962.001).
  • [ISSN] 1365-2516
  • [Journal-full-title] Haemophilia : the official journal of the World Federation of Hemophilia
  • [ISO-abbreviation] Haemophilia
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Blood Coagulation Factor Inhibitors; 0 / Hemostatics; 0 / Recombinant Proteins; 0 / recombinant FVIIa; 9001-27-8 / Factor VIII; EC 3.4.21.21 / Factor VIIa; EC 3.4.21.5 / Thrombin
  •  go-up   go-down






Advertisement